4 stories this morning, for surgeons and the people who support them.
- Enovis makes a binding offer for eCential Robotics — €155M enterprise value, earnout tied to knee and shoulder — Announced Sept 1, 2026: Enovis (NYSE: ENOV) entered a binding offer to acquire French surgical robotics developer eCential Robotics at €155M upfront enterprise value, roughly €176M cash to shareholders at closing, plus up to €35M contingent on milestones. Expected to close in Q4 2026 following the French works council information-and-consultation process and regulatory approvals. eCential's Op.n platform combines navigation and active robotics and is FDA 510(k)-cleared for spine in the US. Enovis says the deal extends its ASTRA ecosystem into robotics, with a next-generation total knee platform to launch within two years, initial commercial contribution in 2028, and a shoulder application after that. Follows Spineart's Aug 26 PERLA TL 510(k) clearance to run on the same platform, covered in the Aug 31 episode. Source
- Medtronic invests ~$700M in Cornerstone Robotics for ex-US distribution rights to Sentire — Announced Sept 1, 2026: Medtronic made an approximately $700M strategic investment in Cornerstone Robotics and took rights to distribute the Sentire surgical system in select markets outside the US where it is market approved. Sentire holds CE Mark (May 2026) for minimally invasive general, gynecologic, thoracic and urologic procedures, plus market approval in China and Singapore. Medtronic will carry Sentire as a complement to Hugo, which it says operates in more than 35 countries. The release states global adoption of robotic-assisted surgery is still in the single digits. Source
- Stryker's SportSuite Vision runs the first Apple Vision Pro hip arthroscopy, at Duke Health — Announced Sept 1, 2026: Stryker completed the first surgical case using SportSuite Vision on Apple Vision Pro — a hip arthroscopy at Duke Health by Chad Mather III, MD, MBA. The software received FDA De Novo authorization on July 17, 2026, the first application authorized for intraoperative use with Apple Vision Pro. Indications for use: intraoperative display of arthroscopic video and medical imaging during femoroacetabular impingement and labral repair hip arthroscopy, and display of the same information presented by HipCheck software and HipMap FAI Analysis. Integrates arthroscopic video, CT, HipCheck and HipMap into the surgeon's field of view. Source
- Stryker signs a definitive agreement for ZuriMED and its FiberLocker rotator cuff augmentation system — Announced Aug 31, 2026: Stryker signed a definitive agreement to acquire privately held ZuriMED, developer of the commercialized FiberLocker System for rotator cuff augmentation — a soft tissue augmentation technology Stryker describes as designed for increased biomechanical strength and to reduce the occurrence of a key clinical failure mode in rotator cuff repair. Financial terms undisclosed; subject to customary closing conditions. Source
Contribute to the Brief
Faculty can send the show a note — a reaction to a paper, a correction, a read on a rule change — either written, which we shape for broadcast and read in the show's voice, or as a voice note under three minutes, which airs in your own voice. Send one from Studio.
Not on doc social yet? Contribute a lecture or join the network — doc social is a clinical education platform for clinicians, and this show is one part of it.
Narration is synthesized. Reporting and editorial judgement are ours, and every story above links to its source.